Round Type
Venture
High PointBiotechnologyHealth CareMedicalDescription
vTv Therapeutics Inc. (Nasdaq: VTVT) today announced entry into agreements that include a $10 million investment by CinPax, LLC (“CinPax”), a subsidiary of CinRx Pharma, LLC (“CinRx”). Under the terms of the agreements, CinPax acquired 4,154,549 shares of Class A Common Stock of vTv at an issue price of approximately $2.41 per share, with $6 million paid in cash at closing, and the remaining amount of $4 million payable on November 22, 2022. The agreements also provide for the issuance of 1.2 million warrants to CinRx to acquire additional shares of Class A Common Stock that become exercisable upon agreed vesting triggers (including FDA approval of TTP399 (“FDA Approval”))
Who to call at vTv, and when
A new round usually means vTv is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day vTv raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at vTv, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment vTv raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
vTv raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.